Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531

被引：7

作者：

Gamis, Alan S. ^{[1
]}

Alonzo, Todd A. ^{[2
]}

Gerbing, Robert B. ^{[3
]}

Aplenc, Richard ^{[4
]}

Sung, Lillian ^{[5
]}

Meshinchi, Soheil ^{[6
]}

Raimondi, Susana C. ^{[7
]}

Hirsch, Betsy A. ^{[8
]}

Kahwash, Samir ^{[9
]}

Heerema-McKenney, Amy ^{[10
]}

Winter, Laura ^{[11
]}

Glick, Kathleen ^{[12
]}

Byron, Patti ^{[13
]}

Burden, Laura ^{[3
]}

Wallas, Tanya ^{[3
]}

Davies, Stella M. ^{[14
]}

Smith, Franklin O. ^{[15
]}

机构：

[1] Childrens Mercy Hosp & Clin, Kansas City, MO USA

[2] Univ So Calif, Keck Sch Med, Dept Prevent Med, Arcadia, CA USA

[3] Childrens Oncol Grp, Arcadia, CA USA

[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[5] Hosp Sick Children, Dept Pediat, Div Hem Onc, Toronto, ON M5G 1X8, Canada

[6] Fred Hutchinson Canc Rsrch Ctr, Seattle, WA USA

[7] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA

[8] Univ Minnesota, Div Lab Med, Med Ctr Fairview, Minneapolis, MN USA

[9] Nationwide Childrens Hosp, Columbus, OH USA

[10] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[11] Seattle Childrens Hosp, Seattle, WA USA

[12] Maine Childrens Canc Program, Scarborough, ME USA

[13] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada

[14] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA

[15] Childrens Hosp, Med Ctr, Div Hematol & Oncol, Cincinnati, OH 45229 USA

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

10.1182/blood.V116.21.182.182

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：83 / 84

页数：2

共 26 条

[1] Gemtuzumab Ozogamicin (GO) in Infants with Acute Myeloid Leukemia (AML) - Combined Results from the Children's Oncology Group (COG) Trials, AAML03P1 and AAML0531
Guest, Erin M.
Aplenc, Richard
Sung, Lillian
Raimondi, Susana C.
Hirsch, Betsy A.
Alonzo, Todd A.
Gerbing, Robert B.
Wang, Yi-Cheng
Kahwash, Samir B.
Heerema-McKenney, Amy
Meshinchi, Soheil
Gamis, Alan S.
BLOOD, 2014, 124 (21)
[2] Relapse Following Initial Remission and Subsequent Outcome for Children with Relapsed Acute Myeloid Leukemia on the AAML0531 Phase III Study of Gemtuzumab Ozogamicin: A Report from the Children's Oncology Group
Cooper, Todd M.
Gerbing, Robert B.
Alonzo, Todd A.
Pollard, Jessica
Sung, Lillian
Kolb, E. Anders
Aplenc, Richard
Meshinchi, Soheil
Gamis, Alan S.
BLOOD, 2016, 128 (22)
[3] Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML0531
Pardo, Laura
Brodersen, Lisa Eidenschink
Lamba, Jatinder K.
Alonzo, Todd A.
Wang, Yi-Cheng
Paine, Dana
Gamis, Alan S.
Kolb, E. Anders
Pollard, Jessica A.
Cooper, Todd M.
Aplenc, Richard
Meshinchi, Soheil
Loken, Michael R.
BLOOD, 2018, 132
[4] Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531
Guest, Erin M.
Aplenc, Richard
Sung, Lillian
Raimondi, Susana C.
Hirsch, Betsy A.
Alonzo, Todd A.
Gerbing, Robert B.
Wang, Yi-Cheng Jim
Kahwash, Samir B.
Heerema-McKenney, Amy
Meshinchi, Soheil
Gamis, Alan S.
BLOOD, 2017, 130 (07) : 943 - 945
[5] Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk - Results From The Randomized Phase III Children's Oncology Group (COG) Trial, AAML0531
Gamis, Alan S.
Aplenc, Richard
Alonzo, Todd A.
Sung, Lillian
Meshinchi, Soheil
Gerbing, Robert B.
Raimondi, Susana C.
Hirsch, Betsy
Kahwash, Samir
McKenney, Amy Heerema
Winter, Laura
Glick, Kathleen
Davies, Stella M.
Byron, Patti
Smith, Franklin O.
BLOOD, 2013, 122 (21)
[6] Treatment of 11q23/MLL + AML with Gemtuzumab Ozogamicin: Results from the Randomized Phase Ill Children's Oncology Group Trial AAML0531
Pollard, Jessica
Alonzo, Todd A.
Cerbing, Robert B.
Raimondi, Susana C.
Hirsch, Betsy A.
Sung, Lillian
Aplenc, Richard
Guest, Erin M.
Bernstein, Irwin D.
Loken, Michael R.
Meshinchi, Soheil
Gamis, Alan S.
BLOOD, 2015, 126 (23)
[7] ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial
Rafiee, Roya
Chauhan, Lata
Alonzo, Todd A.
Wang, Yi-Cheng
Elmasry, Ahlam
Loken, Michael R.
Pollard, Jessica
Aplenc, Richard
Raimondi, Susana
Hirsch, Betsy A.
Bernstein, Irwin D.
Gamis, Alan S.
Meshinchi, Soheil
Lamba, Jatinder K.
BLOOD CANCER JOURNAL, 2019, 9
[8] ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial
Roya Rafiee
Lata Chauhan
Todd A. Alonzo
Yi-Cheng Wang
Ahlam Elmasry
Michael R. Loken
Jessica Pollard
Richard Aplenc
Susana Raimondi
Betsy A. Hirsch
Irwin D. Bernstein
Alan S. Gamis
Soheil Meshinchi
Jatinder K. Lamba
Blood Cancer Journal, 9
[9] CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Pollard, Jessica A.
Loken, Michael
Gerbing, Robert B.
Raimondi, Susana C.
Hirsch, Betsy A.
Aplenc, Richard
Bernstein, Irwin D.
Gamis, Alan S.
Alonzo, Todd A.
Meshinchi, Soheil
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 747 - +
[10] CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
Lamba, Jatinder K.
Chauhan, Lata
Shin, Miyoung
Loken, Michael R.
Pollard, Jessica A.
Wang, Yi-Cheng
Ries, Rhonda E.
Aplenc, Richard
Hirsch, Betsy A.
Raimondi, Susana C.
Walter, Roland B.
Bernstein, Irwin D.
Gamis, Alan S.
Alonzo, Todd A.
Meshinchi, Soheil
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2674 - +

← 1 2 3 →